Tsui DCC, Kavanagh BD, Honce JM, Rossi C, et al. Central Nervous System Response to Selpercartinib in Patient With RET-rearranged Non-small Cell Lung Cancer After Developing Leptomeningeal Disease on Pralsetinib. Clin Lung Cancer 2021 Jun 12. pii: S1525-7304(21)00148.
PMID: 34246540